Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Grapefruit Benefits

Gefitinib Receives European Licence For The Treatment Of Lung Cancer For Patients With EGFR Activating Mutation Positive Tumours
AstraZeneca announced that it has received a licence by the European Medicines Agency (EMEA) for its oral targeted anti-cancer drug, gefitinib, for EGFR (epidermal growth factor receptor-tyrosine kinase) activating mutation positive patients with Non Small Cell Lung Cancer (NSCLC). NSCLC is the most common type of lung cancer and accounts for 80% of all lung cancer cases. [1] The licence means that for the first time, thousands [2] of patients undergoing first line treatment of NSCLC in the UK may benefit from a more effective, [3] oral alternative to doublet chemotherapy (UK standard of care) without many of the side effects associated with chemotherapy. [3]
generic viagra online
For People With Overactive Bladders Botox Injections Can Significantly Improve Quality Of Life
Botox is well known for its cosmetic uses, but researchers have now found that it can also significantly improve people"s quality of life if they suffer from another problem that increases with age, an overactive bladder (OAB).
News of the day
FDA Grants LUCAS™ 2 Chest Compression System 510(k) Clearance In The United States
Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), announced today that LUCAS™ 2, the next-generation LUCAS™ Chest Compression System, has been granted 510(k) market clearance by the U.S. Food and Drug Administration (FDA). Developed and manufactured by Jolife AB and distributed exclusively in the United States by Physio-Control, the LUCAS 2 is an automated, battery-powered device that is designed to give consistent, uninterrupted compressions to victims in cardiac arrest.
Medical Devices

Coalition Commits To Addressing HIV/AIDS In Three U.S. Cities

The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria announced on Capitol Hill on Wednesday that it will help fight the spread of HIV in Washington D.C., New York City and Oakland, Calif., cities among the 20 areas in the U.S. with the highest rates of HIV and AIDS, the Washington Post reports. The coalition - which includes Pfizer, the National Basketball Association, Facebook, Nike, Nokia and others - said it will offer financial donations to city health departments, marketing expertise to promote prevention and treatment campaigns and appearances by professional basketball players for events, as part of their effort. John Newsome, a spokesperson for the coalition, said, "I think the ability of our corporate partners to help develop really effective messages, help provide res to get the message out, contribute talent, air time and media space" is crucial to HIV/AIDS awareness efforts. The coalition plans to expand the effort to other cities in the future (Fears, Washington Post, 6/25). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009